MOG antibody demyelination | Great Ormond Street Hospital
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
MOGAD Awareness Month (1) | We begin MOG Antibody Disease Awareness Month by giving a short description and explanation of MOG antibody disease. MOG antibody disease, or MOGAD, is a... | By
MOG Antibodies Tied to More Pediatric Conditions | MedPage Today
Neuromyelitis Optica (NMO): What It Is, Symptoms & Treatment
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text